Enanta’s lung infection therapy succeeds in mid-stage trialChildren, Clinical Trials, R&D, Respiratory Infections, Respiratory Syncytial Virus (RSV) InfectionEnanta Pharmaceuticals Inc.’s treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study. Read more June 14, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-06-14 06:15:302019-06-24 14:38:04Enanta’s lung infection therapy succeeds in mid-stage trial
